The Different Facades of Retinal and Choroidal Endothelial Cells in Response to Hypoxia

被引:33
作者
Alizadeh, Effat [1 ,2 ]
Mammadzada, Parviz [1 ]
Andre, Helder [1 ]
机构
[1] Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, S-11282 Stockholm, Sweden
[2] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Biotechnol, Tabriz 516615731, Iran
关键词
choroidal endothelial cells; retinal endothelial cells; hypoxia; angiogenesis; differential expression; INDUCIBLE FACTOR-I; GLUCOCORTICOID-RECEPTOR AGONIST; GROWTH-FACTOR EXPRESSION; DIABETIC MACULAR EDEMA; ANTI-VEGF; PIGMENT EPITHELIUM; GENE-EXPRESSION; TISSUE FACTOR; INTUSSUSCEPTIVE ANGIOGENESIS; FACTOR-1-ALPHA AND-2-ALPHA;
D O I
10.3390/ijms19123846
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ocular angiogenic diseases, such as proliferative diabetic retinopathy and neovascular age-related macular degeneration, are associated with severe loss of vision. These pathologies originate from different vascular beds, retinal and choroidal microvasculatures, respectively. The activation of endothelial cells (EC) plays pivotal roles in angiogenesis, often triggered by oxygen deficiency. Hypoxia-inducible factors in ECs mediate the transcription of multiple angiogenic genes, including the canonical vascular endothelial growth factors. ECs show notable heterogeneity in function, structure, and disease, therefore the understanding of retinal/choroidal ECs (REC; CEC) biochemical and molecular responses to hypoxia may offer key insights into tissue-specific vascular targeting treatments. The aim of this review is to discuss the differences spanning between REC and CEC, with focus on their response to hypoxia, which could provide innovative and sustainable strategies for site specific targeting of ocular neovascularization.
引用
收藏
页数:24
相关论文
共 166 条
  • [1] Expression of hypoxia-inducible factor-1α and the protein products of its target genes in diabetic fibrovascular epiretinal membranes
    Abu El-Asrar, Ahmed M.
    Missotten, Luc
    Geboes, Karel
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (06) : 822 - 826
  • [2] Adair TH MJ., 2010, Angiogenesis
  • [3] Endothelial Cell Heterogeneity
    Aird, William C.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (01):
  • [4] Targeting VEGF in eye neovascularization: What's new? A comprehensive review on current therapies and oligonucleotide-based interventions under development
    Amadio, Marialaura
    Govoni, Stefano
    Pascale, Alessia
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 103 : 253 - 269
  • [6] Defining response to anti-VEGF therapies in neovascular AMD
    Amoaku, W. M.
    Chakravarthy, U.
    Gale, R.
    Gavin, M.
    Ghanchi, F.
    Gibson, J.
    Harding, S.
    Johnston, R. L.
    Kelly, S.
    Lotery, A.
    Mahmood, S.
    Menon, G.
    Sivaprasad, S.
    Talks, J.
    Tufail, A.
    Yang, Y.
    [J]. EYE, 2015, 29 (06) : 721 - 731
  • [7] Anand-Apte B., 2010, DEV ANATOMY RETINAL, DOI [10.1016/B978-0-12-374203-2.00169-X, DOI 10.1016/B978-0-12-374203-2.00169-X]
  • [8] Identification of an Alternative Mechanism of Degradation of the Hypoxia-inducible Factor-1α
    Andre, Helder
    Pereira, Teresa S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (43) : 29375 - 29384
  • [9] Hypoxia-Inducible Factor-1α Is Associated With Sprouting Angiogenesis in the Murine Laser-Induced Choroidal Neovascularization Model
    Andre, Helder
    Tunik, Selcuk
    Aronsson, Monica
    Kvanta, Anders
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (11) : 6591 - 6604
  • [10] [Anonymous], 2011, JOVE J VIS EXP AUG, DOI DOI 10.3791/2899